Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
- PMID: 36983672
- PMCID: PMC10053654
- DOI: 10.3390/jpm13030490
Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
Abstract
A unique translational medicine conference for research into treatments that can benefit individuals with neurodevelopmental disorders (NDD), including autism spectrum disorder (ASD), has been developed and hosted by The BRAIN Foundation (Pleasanton, CA, USA) since 2019 [...].
Conflict of interest statement
Frye receives grants from The BRAIN Foundation which is unrelated to this work. H.N. declares no conflicts of interest.
References
-
- Morton J.T., Jin D.-M., Mills R.H., Shao Y., Rahman G., McDonald D., Berding K., Needham B.D., Zurita M.F., David M., et al. Multi-omic analysis along gut-brain axis points to a functional architecture of autism. bioRxiv. 2022 doi: 10.1101/2022.02.25.482050. - DOI
Publication types
LinkOut - more resources
Full Text Sources